Gain-of-function mutations or aberrant activation of the cGAS-STING pathway may participate in the pathogenesis of myelopoiesis-associated clonal hematopoiesis and myeloid malignancies (75, 101, 102). The gene discussed is STING1; the disease is myeloid neoplasm.